Haifaa Abdulhaq

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Mesenchymal Stem Cells

Multiple Myeloma

Chronic Lymphocytic Leukemia

Top Venues

Case reports in hematology

OncoTargets and therapy

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Haifaa Abdulhaq, Andrew Hwang, Omar Mahmood
Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context. OncoTargets and therapy 16 (2023)
Schjesvold Fredrik, Heinz Ludwig, Maria-Victoria Mateos-Manteca, Alessandra Larocca, Haifaa Abdulhaq, Stefan Norin, Marcus Thuresson, Nicolaas A Bakker, Paul Gerard Richardson, Pieter Sonneveld
Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study. European journal of haematology (2023)
Matthew Lee, Beth A Martin, Haifaa Abdulhaq
Daratumumab, Lenalidomide, and Dexamethasone (DRD), an Active Regimen in the Treatment of Immunosuppression-Associated Plasmablastic Lymphoma (PBL) in the Setting of Gorham's Lymphangiomatosis: Review of the Literature. Case reports in hematology 2022 (2022)
Salimah Valliani, Mir Ali, Omar Mahmoo, Sanjay Hinduja, Calvin K Chen, Lloyd E Damon, Haifaa Abdulhaq
Efficacy of Venetoclax and Dexamethasone in Refractory IgM Primary Plasma Cell Leukemia with t(11;14) and TP53 Mutation: A Case Report and Literature Review. Case reports in hematology 2020 (2020)